Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, March 08, 2011

SGO: MicroRNA May Help Predict Ovarian Ca Response - in Meeting Coverage, SGO from MedPage Today

"Changes in expression of a microRNA showed potential for predicting response to the angiogenesis inhibitor bevacizumab (Avastin) in recurrent serous ovarian cancer, according to results of a small study reported here..........."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.